These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 29288528)

  • 1. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
    Tang Q; Len Q; Liu Z; Wang W
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts.
    Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L
    Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
    Sun H; Wang C; Zhou Y; Cheng X
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
    Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
    J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
    Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
    Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
    Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of MicroRNA-137 Improves High Glucose-Induced Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells by Up-Regulation of AMPKα1.
    Li J; Li J; Wei T; Li J
    Cell Physiol Biochem; 2016; 39(3):847-59. PubMed ID: 27497953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
    Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
    Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
    Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
    Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model.
    Yu H; Zhen J; Yang Y; Gu J; Wu S; Liu Q
    J Cell Mol Med; 2016 Apr; 20(4):623-31. PubMed ID: 26869403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2.
    Liu Z; Zhao N; Zhu H; Zhu S; Pan S; Xu J; Zhang X; Zhang Y; Wang J
    Cardiovasc Diabetol; 2015 Sep; 14():125. PubMed ID: 26394923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
    Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
    Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
    Wu W; Liu X; Han L
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
    Yang H; Mao Y; Tan B; Luo S; Zhu Y
    Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.